Enterprise League logo

Biotechnology Companies in United States (US)

Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 633 companies in this sector. The largest share of listings is based in Orlando. Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
633 companies
Orlando top city

Biotechnology
List of Biotechnology companies in United States (US)

633 companies

Sort by

AS ONE INTERNATIONAL, INC., located in Santa Clara California, is committed to bringing innovative science technologies from around the world into the hands of every researcher. AS ONE INTERNATIONAL, Inc. is a subsidiary of AS ONE CORPORATION (www.as-1.co.jp/en) listed in the Prime section of the Tokyo Stock Exchange in Japan. < AS ONE CORPORATION > ASONE Corporation is the leading distributor with the well-known e-commerce and catalog of the laboratory and medical products within Japanese market. -Established: 1933 -Head Quarter: Osaka Japan -Employee: Over 650 -Dealers: Over 5000 companies in Japan -E-commerce Website: Listed 9,000,000SKU (https://axel.as-1.co.jp/) As a subsidiary of ASONE Corporation, we handle the orders and inquiries from the Japanese researchers and ship the goods by consolidating the items at our US warehouse to offer the best price. We also have an ability to import innovative and high-quality products from Japan. AS ONE International distributes the Gravity Control Device “Gravite®” which emulates microgravity.
Biotechnology

2016

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Biotechnology

2008

Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations. For more information, please go to www.palvellatx.com.
Biotechnology

2015

Sable Systems International is the world leader for precision metabolic measurement. We merge authoritative expertise in metabolic physiology and biophysics with an inventive spark to create precision tools for metabolic measurement, neurophysiology and environmental science. The spectrum of applications that can benefit from Sable Systems solutions is vast – from animal biology to pharmaceutical safety testing, human exercise energetics to insect metabolism, and atmospheric monitoring and control. The principles are elegantly simple: measure and control O2, CO2, H2O, methane, pressure and temperature – and do it very well. Our compact, turnkey solutions for high-resolution gas analysis and control, respirometry, indirect calorimetry and animal behavior measurement produce high-definition results.
Biotechnology

1987

Canfield Scientific, Inc., is the global leader in imaging systems services and products for healthcare and scientific research applications. Canfield offers leading edge clinical imaging solutions for medical practices and skin care professionals as well as the pharmaceutical, biotechnology and cosmetics industries. Driven by a quality-focused mission to provide best-in-class products and services, Canfield has achieved an industry-wide reputation for excellence and innovation.
Biotechnology

1988

Huminn Convergence Innovation™ operates on the principle that nature is an interdependent and complex system in order to benefit the entire network and not just its separate domains Convergence Innovation™ Uniquely integrated Platform: Huminn is an innovations company at the forefront of science and technology. Working with leading, interdisciplinary scientists, Huminn deploys cutting-edge precision molecular biology tools with proprietary and novel statistical rediction algorithms to create and commercialize visionary integrated solutions to critical global challenges in health, wellness and sustainable development Huminn connects dots - Others compartmentalize. Huminn connects dots. Others see problems. Huminn marries new tech, new thinking, and a new cast of collaborators to create sustainable solutions that have significant positive economic, environmental and cultural impact
Biotechnology

2015

Plant Health Care is a leading provider of scientifically proven biological products for agriculture. The Company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables. Our innovative line of patent protected products provides both economic and environmental benefits for our customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth. Plant Health Care has global reach through operating subsidiaries and supply agreements with major industry an distribution partners.
Biotechnology

1995

ReproTech is committed to maintaining the highest level of expertise in the reproductive tissue banking industry by ensuring the safety and accuracy of the tissues entrusted to us. Our rigorous quality controls ensure that shipments are safe and efficient, and we believe in the highest standards of safe storage for our clients'​ cryopreserved reproductive tissues which include frequent manual tank inspections and sophisticated 24/7 monitoring systems and analysis. We are dedicated to assisting our clinical partners with regulatory compliance in the areas of tissue storage, donor gametes, and donor embryos.
Biotechnology

1990

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Biotechnology

2013

Discovery Life Sciences, the Biospecimen and Biomarker Specialists™, is a leading provider of highly characterized human biospecimens and cellular starting materials integrated with expert multi-omic analytical services to advance cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions. Our robust biospecimen and biomarker platform is optimized for speed and large scale capacity. We routinely manage hundreds of studies and expertly test thousands of biospecimens simultaneously as a single vendor - eliminating time consuming and inefficient transfers of biospecimens or data between different vendors. We offer one of the largest recallable donor pools, Research Use Only (RUO) and clinical-grade (GMP) fresh and cryopreserved human cellular materials to support cell and gene therapy programs at any scale from start to finish. Leading biopharma, diagnostic and academic institutions trust us to quickly deliver high-quality biospecimens and reliable, reproducible biomarker data, so they can outpace their competition and push the leading edge of innovation. Visit www.dls.com to learn more
Biotechnology

2018

P.I.CelKem is a specialized cell science company based in Tacoma, Washington, dedicated to providing custom protein research and development services to the biotechnology industry. We support researchers and organizations with a comprehensive suite of offerings, including gene design, microbial and mammalian protein expression, protein formulation, and protein characterization. Our expertise lies in delivering high-quality reagents, contract research, and consumables crucial for analysis, discovery, and diagnostics – particularly within the field of pulmonary fibrosis research.

With over 200 completed projects and a team of experienced molecular biologists, P.I.CelKem accelerates innovation and supports the growth of local biotech talent. We are currently expanding our portfolio to include biomolecule reagents, assay kits, and imaging products, furthering our commitment to advancing scientific discovery.
Biopharma
Biotechnology
Life Science

2018

BienaTech is a leading materials innovation company based in Akron, Ohio, specializing in the development of advanced functional materials – including polymers, composites, coatings, thin films, and membranes – for a wide range of industries. We provide cutting-edge solutions to businesses seeking to de-risk their technology development through our expertise in advanced manufacturing and high-performance computing. BienaTech supports clients in sectors such as aerospace, automotive, and industrial manufacturing, enabling them to create lighter, stronger, and more durable products.

Our focus on functional coatings and materials science allows us to address complex challenges and drive innovation in demanding applications. With a team of experienced scientists and engineers, BienaTech is dedicated to accelerating the adoption of sustainable materials and technologies, contributing to a more resilient and efficient future economy.
Advanced Materials
Nanotechnology
Biotechnology

2011

Light-Hope Diagnostics, Inc. is a pioneering biotechnology company based in Salt Lake City, Utah, dedicated to transforming cancer diagnostics through innovative, non-invasive PCR-based tests. We specialize in developing liquid biopsy solutions that detect early-stage cancer with unparalleled accuracy and accessibility, eliminating the need for complex cold chain logistics. Our technology, combining advanced PCR with a proprietary AI model, analyzes small non-coding RNAs from blood samples, offering a significant advancement in early cancer detection.

Light-Hope Diagnostics is committed to saving lives and reducing the global burden of cancer by making timely and affordable diagnostics available to everyone, worldwide. With a multidisciplinary team of experienced scientists, clinicians, and business leaders, we are driving the future of cancer diagnostics, building upon decades of combined expertise in molecular diagnostics, venture investment, and entrepreneurship.
Biopharma
Biotechnology
Life Science

2024

Liquid Sports Lab is a quantitative sports engineering and life science service provider based in Rochester, New York, specializing in advanced athlete performance analysis and training. Leveraging a foundation in computational sciences and biomechanical research, we empower athletes – from MLB and NBA players to collegiate and high school athletes – to reach their full potential. Our approach combines rigorous data analysis, cutting-edge technology, and expert coaching to deliver personalized training programs that optimize mechanics, enhance velocity, and minimize injury risk.

We’ve established a reputation for transforming athletes through a systematic, science-backed methodology, as evidenced by testimonials from athletes across various levels of competition. We are committed to providing a data-driven, results-oriented experience, guaranteeing a measurable improvement in performance or your money back.
Biopharma
Biotechnology
Life Science

2020

Cytozyme is a leading provider of naturally derived agricultural solutions, headquartered in Salt Lake City, Utah, dedicated to enhancing crop yields and quality for growers worldwide. Since 1975, we’ve combined over 40 years of expertise in agronomy, plant physiology, and molecular biology to develop innovative technologies that support plant growth at a cellular level. Our products increase metabolic function and antioxidant activity, bolstering plant resilience and promoting consistent performance across diverse growing conditions – from apple orchards to rice fields.

We work collaboratively with scientists and growers globally, delivering environmentally friendly solutions that improve ROI and contribute to sustainable food production. Cytozyme’s commitment to scientific advancement and practical application ensures growers can achieve healthier, stronger plants and maximize their harvests.
Biopharma
Biotechnology
Life Science

1975

Photon Biosciences is a Washington-based biotechnology company specializing in the development of next-generation diagnostic platforms. We are revolutionizing disease detection and prevention through our PBSDX platform, combining advanced bioengineered proteins, AI/ML algorithms, and optical technologies. Our core technology, PBS, enables ultrasensitive detection, offering portable and rapid diagnostic testing solutions for human and animal health. With a focus on improving healthcare accessibility and speed, Photon Biosciences is dedicated to delivering innovative solutions for heart failure diagnosis, bacterial contamination detection in blood platelets, and a growing portfolio of companion animal diagnostic tests. Founded in 2017, we are committed to transforming healthcare through cutting-edge imaging and analytical technologies.
Biopharma
Biotechnology
Life Science

2017

Vaxonyx is an AI-powered biotechnology company based in Huntsville, Alabama, specializing in the development of innovative genetic, vaccine, and immunotherapy solutions. Leveraging the power of artificial intelligence and molecular biology, we accelerate the discovery and design of next-generation therapeutics, making biomedical innovation accessible and affordable for researchers and healthcare systems worldwide. Our core expertise lies in neoantigen discovery, vaccine design, and translational immunology, underpinned by our integrated DNA Delivery Platform and robust preclinical R&D capabilities. We are committed to transforming scientific breakthroughs into real-world health solutions, driven by a multidisciplinary team of scientists and engineers led by Dr. Kempaiah Rayavara, a seasoned biotech executive with a proven track record in preclinical research and development. Vaxonyx’s vision is to lead globally in AI-driven biotechnology by creating advanced DNA platforms that revolutionize vaccine and gene therapy development, setting new standards for precision and effectiveness.
Biopharma
Biotechnology
Life Science

2025

Delavie Sciences is a pioneering biotechnology company based in Worcester, Massachusetts, specializing in the development of advanced skincare ingredients derived from extremophiles – resilient microorganisms found in extreme environments. Leveraging cutting-edge research and collaborations with leading scientific institutions, we harness the power of these unique organisms to create scientifically-backed skincare solutions. Our focus is on strengthening the skin’s first layer, promoting longevity and resilience against environmental stressors, and delivering visible results. Delavie Sciences is committed to cruelty-free practices and utilizes clinically tested formulations, reflecting our dedication to both scientific innovation and ethical standards. We are transforming the skincare industry by unlocking the secrets of nature’s most enduring champions.
Biopharma
Biotechnology
Life Science

2021

Reliant Glycosciences, LLC is a leading biotechnology company specializing in the development and commercialization of diagnostic and prognostic tools for IgA nephropathy (IgAN), a significant cause of chronic kidney disease. Based in Birmingham, Alabama, we are dedicated to improving patient outcomes through the GalD Assay, a standardized lectin-based ELISA that quantitatively measures galactose-deficient IgA1 (Gd-IgA1) in human serum. Our mission is to provide researchers and pharmaceutical companies with a critical biomarker to accelerate the development of effective therapies for this widespread condition. Founded in 2015 as a spin-out from the University of Alabama at Birmingham, Reliant Glycosciences leverages cutting-edge research to address an unmet need in IgAN management, aligning with the KDIGO guidelines and supporting the advancement of disease-specific treatments. We are committed to providing reliable and accessible tools to the IgAN research community and beyond.
Biopharma
Biotechnology
Life Science

2015

Technology Commercialization Partners (TCP) is a Birmingham, Alabama-based technology commercialization firm dedicated to helping technology creators, small and growing technology-based companies, and inventors successfully bring their innovations to market. Founded by experienced biotechnology entrepreneurs, TCP provides specialized expertise in drug development, life sciences technologies, analytical instrumentation, medical devices, and contract research and manufacturing. We bridge the gap between groundbreaking research and tangible products, leveraging our partners’ deep industry knowledge and operational experience to accelerate commercialization timelines and maximize return on investment. With a proven track record of assisting inventors in navigating the complexities of bringing technologies to market, TCP offers a collaborative and strategic approach, ensuring that innovative ideas translate into valuable, revenue-generating products and services. Our team’s combined experience in areas such as medical science research, device delivery, and vaccine development, coupled with our focus on reducing surgical interventions and improving device longevity, positions us as a trusted partner for companies seeking to transform their technologies into impactful solutions.
Biopharma
Biotechnology
Life Science

2015

FasTrain Courses is a Vancouver-based training provider specializing in comprehensive professional development for the bio/pharmaceutical and biotech industries. We deliver interactive online courses designed to meet stringent FDA, EMA, and other regulatory agency training requirements. Our experienced instructors, practicing professionals, offer practical knowledge and solutions to help companies in the global market. We focus on solving technical and regulatory challenges, providing a competitive edge for small, medium, and large organizations involved in product development.

FasTrain Courses offers a wide range of courses, including CMC, sourcing biological raw materials, forced degradation, stability testing, and statistical methods. Our commitment is to provide flexible, accessible training that saves time and reduces travel costs.

Our key differentiators include our experienced instructors, stand-alone session format, and readily available recordings, ensuring flexibility for busy professionals. We also offer a comprehensive certification program and ongoing updates on cGXP regulations.

Biopharma
Biotechnology
Life Science

2009

Nectero Therapeutics is a clinical-stage biotech company based in Tempe, Arizona, dedicated to transforming the treatment of aneurysmal disease. We are pioneering novel therapies, specifically the Nectero EAST ® System, to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms (AAA). Our approach utilizes an endovascular technique to deliver a proprietary mixture, minimizing the need for major intervention like EVAR or open surgery. Led by a highly accomplished, multidisciplinary management team and supported by renowned physician leaders, Nectero Therapeutics is committed to improving patient outcomes and extending lives.

The Nectero EAST ® System offers a promising alternative for patients with AAAs that may not otherwise qualify for traditional treatment options. By strengthening the aortic tissue around the aneurysm, we aim to significantly delay or prevent the need for invasive procedures. We are focused on developing innovative solutions to address a significant public health concern.

Nectero Medical, Inc. (DBA Nectero Therapeutics) is at the forefront of this research, driven by a passion for advancing vascular medicine and providing hope for patients and their families. We are dedicated to rigorous clinical development and regulatory compliance, ensuring the safety and efficacy of our therapies.

Biopharma
Biotechnology
Life Science

2017

Immunowake, Inc. is a biotechnology company based in Birmingham, Alabama, specializing in cancer drug discovery. We are dedicated to developing safe and effective cytokine immune modulators, aiming to overcome tumor immune suppression and reactivate the patient’s own immune system to identify and eliminate cancer cells. Our approach, reflected in our name ‘Immunowake,’ focuses on ‘awakening’ the immune system to offer renewed hope. We leverage a robust research platform and a strong research pipeline to treat both cancer and autoimmune diseases.

Our core technology centers on precisely delivering cytokines to maximize their anti-tumor potential while minimizing systemic toxicity. This innovative strategy utilizes cytokines – key players in coordinating immune cell activation – to effectively combat cancer.

Immunowake is building a powerful pipeline of immune cytokine therapies, and recently secured investment from Haiju Talent Investment Fund, further solidifying our position at the forefront of cancer immunotherapy.

Biopharma
Biotechnology
Life Science

2019

CytoDyn is a Vancouver, Washington-based biotechnology company dedicated to developing innovative treatments for solid-tumor oncology and other indications.

We are focused on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor, a protein implicated in a broad range of disease states including cancer metastasis and certain immunological conditions.

Leronlimab’s unique competitive inhibition of the CCR5 receptor offers a paradigm-shifting therapeutic approach, differentiating it from other CCR5 antagonists.

CytoDyn’s commitment is to enhancing the lives of patients through targeted medicine, leveraging the potential of leronlimab across multiple disease areas.
Biopharma
Biotechnology
Life Science
Cardivia Labs is a biotechnology company based in Rochester, New York, focused on developing next-generation RNA therapeutics to reverse vascular aging and treat cardiovascular diseases.

We are pioneering a revolutionary approach to cardiovascular health, targeting the genetic drivers of vascular decline with precision RNA medicines. Our core technology, including Target-Site Blockers (TSBs) and Antisense Oligonucleotides (ASOs), aims to restore vascular health and extend cardiovascular healthspan.

Cardivia Labs’ proprietary miRNA-targeting strategy and cell-specific vascular targeting offer a unique advantage in developing therapies for conditions like atherosclerosis and vascular aging. Our team, led by scientist-founder Ismail Cimen, is dedicated to translating cell-targeted RNA therapeutics into impactful treatments.

Currently, we are advancing programs targeting CXCR4, SIRT6, and TET2, with an IND-enabling study planned for CXCR4-TSB. We are committed to transforming outcomes for millions at risk of heart attack and stroke.
Biopharma
Biotechnology
Life Science

2025

Kailos Genetics is a Huntsville, Alabama-based genetic testing company specializing in physician-ordered genetic tests and hereditary cancer risk screening.

We empower individuals and healthcare providers to make more informed decisions about their health through accessible and affordable precision medicine solutions. Our TargetRichTM enrichment technology and next-generation sequencing capabilities provide comprehensive genetic insights.

Kailos Genetics combines robust next generation sequencing with illuminating, high-powered analytics to produce accurate and comprehensive genetic information. We offer a complete sequencing solution, from assay design to data analysis, and integrate seamlessly into existing laboratory workflows.

Founded in 2010, Kailos Genetics is committed to advancing precision medicine and improving patient outcomes.
Biopharma
Biotechnology
Life Science

2010

NC Life Sciences Organization is a Durham, North Carolina-based nonprofit trade association dedicated to advancing the North Carolina life sciences industry.

We support a diverse ecosystem of companies, from startups to multinational corporations, fostering innovation and collaboration across the sector.

NCLifeSci delivers critical policy and advocacy leadership, drives workforce development programs, and provides invaluable industry connections, enabling our members to thrive in a global marketplace. We champion policies that encourage growth and support a strong life sciences workforce, ultimately contributing to economic opportunity and improved quality of life.

As the leading voice for North Carolina’s life sciences, we are committed to building a vibrant and successful industry for years to come.
Biopharma
Biotechnology
Life Science

1994

Istari Oncology is a Durham, North Carolina-based biotechnology company developing innovative immunotherapy treatments for glioblastoma and other cancers.

Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.

Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.

Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
Biopharma
Biotechnology
Life Science

2016

Belhaven Biopharma is a US-based biotechnology company specializing in the development of innovative dry powder nasal medicines for emergency treatment of severe allergic reactions and anaphylaxis.

We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.

Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.

Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
Biopharma
Biotechnology
Life Science

2021

PolarisQB is a Research and Development company based in RTP, North Carolina, pioneering the field of Quantum-Aided Drug Design (QuADD).

We leverage the power of quantum computing to revolutionize drug discovery, compressing the lead time for pre-clinical drug candidates from five years to just four months. This allows us to generate up to 100 drug blueprints annually, enabling rapid adaptation within the precision medicine market.

PolarisQB’s unique approach utilizes Quantum Annealing and Quantum Inspired Algorithms to explore a chemical space far exceeding the capabilities of traditional methods – over 10^30 chemical spaces compared to the limitations of conventional screening. We are dedicated to accelerating the development of novel therapeutics and personalized medicine solutions.

Founded in 2020, PolarisQB is rapidly establishing itself as a leader in computational chemistry, with a team of experts and a growing portfolio of intellectual property. We collaborate with pharmaceutical, biotech, and agricultural companies to unlock the potential of quantum computing for drug design.
Biopharma
Biotechnology
Life Science

2020

Aceragen is a Durham, North Carolina-based rare disease biopharmaceutical company focused on developing and commercializing innovative therapies for patients with debilitating conditions.

Following the merger with Idera Pharmaceuticals in 2022, Aceragen is dedicated to advancing its pipeline of novel treatments, particularly in the area of rare genetic diseases. We leverage a patient-centric approach, combining scientific expertise with a deep understanding of the challenges faced by patients and their families.

Aceragen’s core expertise lies in the development of targeted therapies, utilizing innovative technologies to address unmet medical needs. We are committed to improving the lives of patients and their families through the discovery and delivery of transformative medicines. Our team combines decades of experience in drug development, manufacturing, and commercialization, ensuring a robust pathway to market for our promising therapies. We operate with a strong focus on ethical practices and patient well-being.
Biopharma
Biotechnology
Life Science

1989

CytexOrtho is a clinical-stage medical device company based in Durham, North Carolina, dedicated to revolutionizing orthopaedic treatment for cartilage repair.

We’re building on the pioneering tissue regeneration research of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos, leveraging their groundbreaking work to develop innovative implant solutions.

CytexOrtho’s approach focuses on regrowing cartilage and repairing damaged joints, offering a potential alternative to traditional hip replacements and addressing the growing market for osteoarthritis treatment. Our commitment to advancing patient care drives our research and development efforts, aiming to provide effective and lasting solutions for individuals suffering from joint pain.

Currently, our products are in development and not yet approved by the FDA or commercially available. We are focused on bringing this transformative technology to market, contingent upon regulatory approval.
Biopharma
Biotechnology
Life Science

2006

Innatrix is a Research Triangle Park, North Carolina-based agricultural biotechnology company dedicated to developing sustainable, eco-friendly biopesticides for currently untreatable crop diseases and pests.

We transform crop protection with rapid development of new products based on innovative, novel peptides and RNAi that are tailor-made to the needs of farmers. Our core technology, EvoStat, enables the evolution of these products to combat potential pest or pathogen resistance, offering a long-term and cost-effective solution for farmers.

Backed by a team of experienced scientists and significant venture capital funding, Innatrix is committed to empowering farmers to increase yields by at least 10% while achieving a return on investment exceeding 3x. We are focused on providing robust, sustainable solutions to the challenges of crop protection.

Currently, we are developing InnaLB™ for potato late blight, InnaNema™ for soybean cyst nematode, and InnaHLB™ for citrus greening.
Biopharma
Biotechnology
Life Science

2013

Aer Therapeutics is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on developing innovative therapies for muco-obstructive lung diseases.

We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.

AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.

Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
Biopharma
Biotechnology
Life Science

2014

Global Stewardship Group is a Washington, D.C.-based non-profit organization dedicated to advancing plant biotechnology stewardship practices worldwide.

We support companies and organizations across the agricultural biotechnology sector, including seed producers, technology providers, and biotech associations, by offering comprehensive programs focused on transgene technology management, genome editing stewardship, and broader plant breeding innovation.

Our approach centers on flexibility, adaptability, and accessibility, ensuring that our programs integrate seamlessly into existing systems and provide valuable guidance to organizations of all sizes. We help ensure quality products reach the market, fostering trust with growers and consumers through robust stewardship practices.

Founded in 2008 as Excellence Through Stewardship, we’ve grown to encompass the Global Stewardship Group, reflecting our expanded scope of services and commitment to a more sustainable and responsible biotechnology landscape.
Biopharma
Biotechnology
Life Science
Bontera BioAg is a Dallas, Texas-based provider of microbial technologies, dedicated to enhancing agricultural practices and promoting sustainable soil health.

We specialize in developing and delivering innovative biological solutions for growers seeking to improve crop yield, quality, and overall profitability. Bontera’s approach centers on harnessing the power of naturally-occurring soil microbes – including Bacillus, Trichodermas, and Rhizobium – to create robust root development, increased nutrient availability, and enhanced plant health.

Our custom blend solutions and market-ready products are 100% organically derived, compatible with sustainable and organic growing practices, and represent a commitment to nurturing land health for future generations. We work with growers to tailor microbial blends to specific crop and soil needs, supporting a more resilient and productive agricultural ecosystem.
Biopharma
Biotechnology
Life Science

2014

BioAesthetics is a US-based biotechnology company specializing in tissue-engineered solutions for breast reconstruction. Founded in 2015 as a Tulane University spin-out, we develop innovative products to improve outcomes for patients undergoing mastectomies.

Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.

BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.

We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.
Biopharma
Biotechnology
Life Science

2015

ELEXAN Scientific is a California-based microfluidics and microfabrication supply company, dedicated to simplifying access to high-performance fluidic technologies.

We provide a comprehensive selection of fittings, connectors, tubing, and flow control equipment, ensuring researchers and engineers have the essential components for their experiments and manufacturing processes. Our commitment to rapid order fulfillment from our Irvine facility allows you to focus on innovation, while our diverse product range caters to a wide spectrum of applications.

ELEXAN Scientific is your trusted partner for reliable, high-quality microfluidic solutions, supporting advancements across biotechnology research and beyond. We strive to streamline your sourcing experience, empowering you to push the boundaries of discovery.
Biopharma
Biotechnology
Life Science

2024

Micoy Therapeutics is a Jersey City, New Jersey-based biotechnology company pioneering therapies to block harmful autoantibodies and strengthen immune defenses.

We are dedicated to revolutionizing the treatment of life-threatening viral infections and cancer by addressing a previously overlooked vulnerability: the presence of harmful autoantibodies that impair the immune system’s ability to combat viruses or respond effectively to anticancer therapy.

Micoy Therapeutics develops targeted therapies and companion diagnostics, including the NeuroLume™ rapid test for Folate Receptor Autoantibodies (FRAAs) and decoy biologics to neutralize Type I Interferon Autoantibodies. Our innovative approach combines immunology, protein engineering, and diagnostic innovation to detect and neutralize these autoantibodies early, restoring immune balance and protecting individuals from a wide range of viral threats.

Led by a team of experts in drug discovery, immunology, and translational medicine, Micoy Therapeutics is building a platform for immune health across the lifespan, revealing how autoantibodies shape human health and creating practical solutions to restore balance and resilience.
Biopharma
Biotechnology
Life Science

2024

AchieveBio is a leading search firm specializing in recruitment for the biotechnology and life science industries, based in Lincoln, Nebraska.

We connect top-tier professionals – including executive management, sales and marketing experts, and technical personnel – with innovative companies and established leaders across North America.

AchieveBio distinguishes itself through a consultative approach, deeply understanding client needs to deliver exceptional candidates. With 15 years of experience and an extensive network, we focus on identifying and securing those top contributors who drive business success.

Founded in 2008, AchieveBio is committed to ethical recruitment practices and building lasting relationships with both clients and candidates, ultimately helping organizations achieve their strategic goals.
Biopharma
Biotechnology
Life Science

2008

Love Contracts is a Durham, North Carolina-based clinical strategic outsourcing solutions provider exclusively supporting small biotech, biopharma, and med devices companies.

We understand the unique challenges faced by these emerging life sciences organizations – lean teams, aggressive timelines, and high-stakes trials – and offer a refreshingly professional approach to outsourcing.

As a results-driven global provider, Love Contracts, now Nova Outsourcing Management, leverages deep, hands-on experience from both the sponsor and CRO sides of the industry to deliver strategic outsourcing solutions, win-win negotiations, and strong vendor partnerships.

Led by Julia Love and Murtza Naseem, Nova helps companies maximize their investments and accelerate their clinical portfolios through innovative outsourcing strategies.
Biopharma
Biotechnology
Life Science

2022

BioLabs North Carolina is a premier biotech coworking facility located in downtown Durham, North Carolina, providing fully equipped, wet lab space for life science companies.

We cater to ambitious startup companies in the biotechnology research sector, offering a collaborative environment with top-of-the-line research equipment. Our goal is to accelerate resident companies’ milestones, reducing capital expenditure through shared resources and expert support.

BioLabs North Carolina simplifies the complexities of early-stage biotech development by offering a streamlined, supportive ecosystem. We are dedicated to fostering innovation and growth within the life sciences industry, connecting entrepreneurs with the tools and network they need to succeed.

Established in 2017, BioLabs North Carolina currently supports a team of 3 professionals and is strategically positioned to become a leading hub for biotech startups in the region.
Biopharma
Biotechnology
Life Science

2017

CBio is a Tampa, Florida-based systems engineering company pioneering solutions to help drug manufacturers bring cell and viral vector gene therapies to patients when they need it most.

CBio builds quality testing equipment and kits using novel separation science techniques, machine vision, and edge computing to ensure the life saving treatments will work as expected and are safe for patients to receive.

What sets CBio apart is our patented technology, which is able to identify microbial contamination and other quality issues such as detection of empty virus particles much faster than todays gold standard methods reducing weeks of testing time to within 48 hours.

Our transformative solution helps address critical issues affecting bio-manufacturing and quality testing to allow release of the powerful life saving treatments to patients when they need it most. We focus on diseases where effective treatments exist but remain out of reach because of cost, manufacturing complexity, or supply constraints. The science is solved. The access isn't.
Biopharma
Biotechnology
Life Science

2016

Grid Therapeutics is a Durham, North Carolina-based biotechnology company focused on developing targeted immunotherapy for cancer.

We are pioneering the first human-derived antibody, designated GT103, to treat refractory non-small cell lung cancer (NSCLC). Our approach leverages exceptional outcomes observed in early lung cancer patients, isolating and engineering a novel antibody from patient B-cells using advanced molecular genomic techniques.

Grid Therapeutics is currently enrolling patients in a Phase 1 clinical trial, representing a significant step forward in personalized cancer treatment. We are dedicated to advancing innovative solutions for patients battling difficult-to-treat cancers.

Founded in 2014, Grid Therapeutics builds upon the groundbreaking research of Edward F. Patz, Jr. MD and his team at Duke University Medical Center, bringing decades of scientific expertise to the development of life-saving therapies.
Biopharma
Biotechnology
Life Science

2014

Pulvinar Neuro is a Durham, North Carolina-based neurotechnology company specializing in innovative and affordable brain stimulation solutions for researchers.

We develop and manufacture the XCSITE 100, a leading tDCS/tACS research system, which is trusted by leading neuroscience labs across the United States. Our mission is to accelerate basic and translational neuroscience research by providing accessible and reliable tools.

Pulvinar Neuro is dedicated to supporting the advancement of neuroscience through continuous technological development and collaboration with the research community. We offer a range of products and services designed to meet the evolving needs of neuroscientists, fostering breakthroughs in understanding the brain.

Since launching the XCSITE 100 in 2016, we’ve grown to a team of 9, committed to pushing the boundaries of neurotechnology.
Biopharma
Biotechnology
Life Science

2016

Tiamat Sciences Corp is a Durham, North Carolina-based plant-based platform and product life sciences company. We are revolutionizing reagent production for the pharmaceutical industry, empowering partners to create innovative therapies while simultaneously reducing material costs, accelerating development timelines, and minimizing environmental impact through a decarbonized supply chain.

Our core offering centers around a proprietary platform that dramatically simplifies and optimizes the creation of high-quality, plant-derived reagents. This allows pharmaceutical companies and biotech firms to focus on their core research and development efforts, rather than being constrained by complex and costly reagent sourcing.

Founded in 2019, Tiamat Sciences is committed to driving sustainable innovation in the life sciences sector. We leverage cutting-edge biotechnology and a deep understanding of plant-based chemistry to deliver a superior alternative to traditional reagent production methods. We are dedicated to supporting the next generation of pharmaceutical products and fostering a more environmentally responsible industry.Plant-based reagents, pharmaceutical industry, biotechnology, sustainable innovation
Biopharma
Biotechnology
Life Science

2019

Myodenovo is a Durham, North Carolina-based biotechnology company pioneering the development of sustainable meat production through advanced bioreactor technology.

We cultivate the highest quality, most tender meats – including prized cuts like filet mignon – without relying on animal agriculture. Our approach mirrors nature’s most efficient processes, utilizing bioreactors and cell scaffolds inspired by greenhouses and plant growth.

Myodenovo’s innovative technology offers a delicious and ethical alternative to traditional meat production, catering to discerning meat aficionados and contributing to a more sustainable food future. We are committed to providing a premium culinary experience while minimizing environmental impact.
Biopharma
Biotechnology
Life Science

2022

Okogen, Inc is a US-based biotechnology company developing innovative therapeutics for ophthalmic infectious diseases, specifically focusing on acute infectious conjunctivitis.

We are dedicated to addressing a significant unmet need in the treatment of pink eye, a common condition affecting millions annually. Our lead product candidate, OKG-0303, is a ‘one-stop shop’ treatment for both bacterial and viral conjunctivitis, offering a comprehensive solution for healthcare professionals.

Okogen’s approach centers on a proprietary formulation combining antiviral, ocular decongestant, and antibacterial agents, aiming to simplify treatment and improve patient outcomes. With a growing market of $4.2 billion annually for conjunctivitis treatments, Okogen is positioned to become a leader in this space.

Currently, we are in Phase 2B clinical trials and have recently secured $3.3M in funding to advance our clinical program. Our team, led by CEO Joshua H. Moriarty and Chief Medical Officer David A. Hollander, brings extensive experience in ophthalmic pharmaceutical development.
Biopharma
Biotechnology
Life Science

2015

NeuroQure is a California-based biotechnology company pioneering early autism risk detection. We’re dedicated to changing lives through groundbreaking innovations, starting with the ASD Insight™ autism risk test – a simple skin test that provides insights into autism risk from birth.

Our mission is to empower parents and healthcare providers with the information they need to take meaningful steps during the critical early stages of development.

ASD Insight™ utilizes a revolutionary cellular biomarker detection technology, built on 8 years of robust academic research, offering a key factor supporting immediate action to learning about access to impactful interventions in children who are on the autism spectrum.

We’ve helped thousands of families gain clarity and access to vital support, and continue to expand our reach through strategic partnerships and ongoing research.
Biopharma
Biotechnology
Life Science

2023

Growth Curve Bio is a Durham, North Carolina-based precision fermentation CDMO/CMO, specializing in benchtop and pilot-scale services.

We support clients across a diverse range of industries – including alternative protein, biopharma, biofuels, and personal care – accelerating their development timelines with a focus on quality, velocity, and simplicity.

Growth Curve Bio provides critical infrastructure and expert support to companies navigating the complexities of precision fermentation, from early-stage research to scale-up. We help you streamline your processes and achieve faster, more reliable results.

Founded in 2023, our team of experienced scientists and engineers is dedicated to empowering innovation in the bioeconomy. We are committed to providing flexible, fee-for-service solutions tailored to your specific needs.
Biopharma
Biotechnology
Life Science

2023

List of Biotechnology companies in United States (US)

Company Name

Location

Category

Employees

Website

Santa Clara, United States (US)

Science and Engineering
Science and Engineering

2-10

http://www.asone-int.com/

Rockville, United States (US)

Science and Engineering
Science and Engineering

200-500

https://www.regenxbio.com

Wayne, United States (US)

Science and Engineering
Science and Engineering

20-30

https://palvellatx.com/

North Las Vegas, United States (US)

Science and Engineering
Science and Engineering

50-100

http://www.sablesys.com

Parsippany, United States (US)

Science and Engineering
Science and Engineering

200-500

http://www.canfieldsci.com

New York, United States (US)

Science and Engineering
Science and Engineering

10-20

https://nr-s.net

Holly Springs, United States (US)

Science and Engineering
Science and Engineering

50-100

http://www.planthealthcare.com

Coconut Creek, United States (US)

Science and Engineering
Science and Engineering

100-150

https://www.reprotech.com

Boston, United States (US)

Science and Engineering
Science and Engineering

200-500

http://www.crisprtx.com

Huntsville, United States (US)

Science and Engineering
Science and Engineering

500-1000

http://www.dls.com

Tacoma, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.picelkem.com

Akron, United States (US)

Manufacturing and Industry
+1
Manufacturing and Industry, Science and Engineering

2-10

https://bienatech.com/

Salt Lake City, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://lighthopediagnostics.com

Rochester, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

http://www.liquidsportslab.com

Salt Lake City, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

50-100

http://www.cytozymeag.com

Spokane, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://photonbiosciences.com/

Huntsville, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.vaxonyx.com/

Worcester, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

https://www.delaviesciences.com/

Birmingham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.reliantglycosciences.com/

Birmingham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://techcompartner.com/

Vancouver, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://fastraincourses.com/

Tempe, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

http://www.necteromedical.com

Birmingham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

https://www.immunowake.com/

VANCOUVER, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

20-30

https://www.cytodyn.com/

Rochester, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.cardivialab.com

Huntsville, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

http://www.KailosGenetics.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.nclifesci.org/

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://istarioncology.com

Research Triangle Park, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.belhavenbio.com

RTP, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.polarisqb.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.aceragen.com/

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://cytexortho.com

Research Triangle Park, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.innatrix.com/

Research Triangle Park, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://aertherapeutics.com

Washington, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://excellencethroughstewardship.org

Dallas, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.bontera.com

Research Triangle Park, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.bio-aesthetics.com

Irvine, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://elexansci.com

Jersey City, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.micoytherapeutics.com/

Lincoln, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://achievebio.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.novaoutsourcingmgmt.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.biolabs.io/location/north-carolina

Tampa, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.cbio.io

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.gridtherapeutics.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.pulvinarneuro.com/

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.tiamat-sciences.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://myodenovo.com

Plano, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.okogen.com

Irvine, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.neuroqure.com

Durham, United States (US)

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.growthcurvebio.com

300/633 results

Frequently asked questions

Updated 23 October 2026

What is Enterprise League?

Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.

Is it free to list my company?

Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.

How does verification work, and what does it cost?

Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.

Where does the company information come from?

Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.

How do I claim or correct my company’s profile?

Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.